People

GenFit’s lead product candidate elafibranor snagged Breakthrough Therapy Designation from the U.S. Food and Drug Administration as a treatment for Primary Biliary Cholangitis (PBC) following strong Phase II results that demonstrated the safety and efficacy of the medication.
The last year has been a busy one for Bedford, Mass.-based Homology Medicines. Albert Seymour, Homology’s chief science officer, took time out to talk to BioSpace about the company and where it’s headed.
Steps have been taken to safeguard the cancer center, including development of a cutting-edge approach to Enterprise Risk Management.
We are highlighting interesting careers in life sciences and we think clinical study coordinator is one of them. Learn more about their job description here.
The California life Sciences Institutes (CLSI) recently named the winners of the 2019 Amgen Bay Area BioGENEius Challenge. This challenge is a Bay Area competition for high school students that focuses on the students’ individual research projects in the life sciences.Lori Lindburg, president and chief executive officer of CLSI, took time to speak with BioSpace about the organization and the Challenge.
Ken Hughes Appointed COO, Kathryn Froh Retiring
Biotech, pharma and life science companies make appointments to leadership roles, with additions at Cerevance, Obsidian, KSQ, Lygos, and more.
There is something of a recurring theme among the life science, healthcare and biopharma industries: shortage of skilled employees will lead to a decrease in innovation.
Director Peter Marks said FY18 was productive and exciting as the FDA department continued to support the advancement of 21st century medicine.
Since GSK initiated this new focus, the company has made several key moves to support the plan, including the December 2018 acquisition of Tesaro Oncology.
PRESS RELEASES